Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optosurgical
Columbia, Maryland, United States
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
Optosurgical develops intraoperative imaging devices, most notably the hANDY-i, to improve tissue and organ visualization for thyroid, parathyroid, hepatobiliary, and intestinal surgeries. Early-phase clinical studies are ongoing, aiming to validate real-time identification and assessment of tissue viability, with goals to reduce surgical complications (such as hypoparathyroidism and bile duct injury)[3].
- Therapeutic areas
- GastroenterologyEndocrinology
- Modalities
- DeviceImaging deviceFluorescence imaging technology
- Industry
- Medical Imaging
02
Partnerships
Johns Hopkins Hospital (clinical validation and research)[3]Children’s National Hospital (intestinal tissue imaging research)[3]
Beyond the preview
Go deeper on Optosurgical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Optosurgical.